Stocks and Investing
Stocks and Investing
Thu, July 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, July 19, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Gerberry Upgraded (BLUE) to Strong Buy and Increased Target to $10 on, Jul 19th, 2023
Jason Gerberry of B of A Securities, Upgraded "bluebird bio, Inc." (BLUE) to Strong Buy and Increased Target from $6 to $10 on, Jul 19th, 2023.
Jason has made no other calls on BLUE in the last 4 months.
There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $8 on, Thursday, March 30th, 2023
These are the ratings of the 3 analyists that currently disagree with Jason
- Matthew Harrison of "Morgan Stanley" Reiterated at Sell and Held Target at $3 on, Tuesday, July 11th, 2023
- Gena Wang of "Barclays" Upgraded from Hold to Buy and Increased Target to $8 on, Thursday, June 1st, 2023
- Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $7 on, Friday, April 28th, 2023
Contributing Sources